UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Scientific reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 7519 - 12
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Hematologic Diseases - pathology | Liver - pathology | Metabolic Diseases - pathology | Respiratory Tract Diseases - metabolism | Kidney - pathology | Skin - metabolism | Hematologic Diseases - metabolism | Humans | Muscle, Skeletal - metabolism | Respiratory Tract Diseases - drug therapy | Respiratory Tract Diseases - genetics | Brain - metabolism | Musculoskeletal Diseases - pathology | Kidney - metabolism | Liver - drug effects | Muscle, Skeletal - drug effects | Myocardium - metabolism | Nervous System Diseases - metabolism | Nutrition Disorders - pathology | Computational Biology - methods | Kidney - drug effects | Liver - metabolism | Nervous System Diseases - drug therapy | Connective Tissue Diseases - metabolism | Neoplasms - drug therapy | Brain - drug effects | Connective Tissue Diseases - drug therapy | Connective Tissue Diseases - pathology | Lung - drug effects | Brain - pathology | Hematologic Diseases - genetics | Prescription Drugs - pharmacokinetics | Digestive System Diseases - pathology | Neoplasms - metabolism | Cardiovascular Diseases - drug therapy | Drugs, Investigational - pharmacokinetics | Respiratory Tract Diseases - pathology | Hematologic Diseases - drug therapy | Metabolic Diseases - drug therapy | Cardiovascular Diseases - pathology | Nervous System Diseases - genetics | Cardiovascular Diseases - genetics | Musculoskeletal Diseases - genetics | Neoplasms - genetics | Lung - metabolism | Skin - pathology | Nervous System Diseases - pathology | Lung - pathology | Musculoskeletal Diseases - drug therapy | Cardiovascular Diseases - metabolism | Musculoskeletal Diseases - metabolism | Nutrition Disorders - drug therapy | Nutrition Disorders - genetics | Myocardium - pathology | Organ Specificity | Digestive System Diseases - genetics | Algorithms | Digestive System Diseases - drug therapy | Nutrition Disorders - metabolism | Metabolic Diseases - metabolism | Digestive System Diseases - metabolism | Metabolic Diseases - genetics | Connective Tissue Diseases - genetics | Muscle, Skeletal - pathology | Neoplasms - pathology | Skin - drug effects | Drug development | Index Medicus
Journal Article
1998, ISBN 0824795164, xii, 709
Book
Annals of the rheumatic diseases, ISSN 0003-4967, 11/2018, Volume 77, Issue 11, pp. 1549 - 1557
treatment | lupus nephritis | systemic lupus erythematosus | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Lupus Erythematosus, Systemic - complications | Musculoskeletal Diseases - drug therapy | Musculoskeletal Diseases - etiology | Standard of Care | Antiphospholipid Syndrome - etiology | Antiphospholipid Syndrome - drug therapy | Humans | Hematologic Diseases - drug therapy | Kidney Diseases - drug therapy | Lupus Nephritis - drug therapy | Skin Diseases - drug therapy | Lung Diseases - drug therapy | Lung Diseases - etiology | Latin America | Lupus Nephritis - etiology | Skin Diseases - etiology | Heart Diseases - etiology | Hematologic Diseases - etiology | Mental Disorders - drug therapy | Lupus Erythematosus, Systemic - drug therapy | Heart Diseases - drug therapy | Kidney Diseases - etiology | Mental Disorders - etiology | Lupus | Anticoagulants | Aspirin | Systemic lupus erythematosus | Glucocorticoids | Socio-economic aspects | Rituximab | Arthritis | Patients | Antiphospholipid syndrome | 1506 | 2311 | Recommendation
Journal Article
International journal of dermatology, ISSN 0011-9059, 03/2010, Volume 49, Issue 3, pp. 239 - 248
Life Sciences & Biomedicine | Dermatology | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | Medical sciences | Prevention and actions | Glucocorticoids - therapeutic use | Endocrine System Diseases - chemically induced | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Male | Metabolic Diseases - drug therapy | Osteoporosis - drug therapy | Femur Head Necrosis - drug therapy | Central Nervous System Diseases - prevention & control | Femur Head Necrosis - prevention & control | Gastrointestinal Diseases - drug therapy | Musculoskeletal Diseases - chemically induced | Aged, 80 and over | Female | Endocrine System Diseases - drug therapy | Glucocorticoids - adverse effects | Musculoskeletal Diseases - prevention & control | Musculoskeletal Diseases - drug therapy | Endocrine System Diseases - prevention & control | Osteoporosis - chemically induced | Osteoporosis - prevention & control | Gastrointestinal Diseases - prevention & control | Metabolic Diseases - chemically induced | Skin Diseases - drug therapy | Femur Head Necrosis - chemically induced | Central Nervous System Diseases - chemically induced | Central Nervous System Diseases - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Metabolic Diseases - prevention & control | Gastrointestinal Diseases - chemically induced | Prevention | Complications and side effects | Usage | Care and treatment | Corticosteroids | Skin diseases | Steroids | Index Medicus
Journal Article
BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, ISSN 1173-8804, 8/2017, Volume 31, Issue 4, pp. 299 - 316
Antibodies | Pharmacotherapy | Cancer Research | Molecular Medicine | Biomedicine | Pharmacology & Pharmacy | Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology | Biosimilar Pharmaceuticals - therapeutic use | Humans | Spondylitis, Ankylosing - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - immunology | Antibodies, Monoclonal - therapeutic use | Infliximab - therapeutic use | Ustekinumab - therapeutic use | Arthritis, Juvenile - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis, Rheumatoid - drug therapy | Abatacept - therapeutic use | Arthritis, Psoriatic - drug therapy | Crohn Disease - drug therapy | Colitis, Ulcerative - drug therapy | Antibodies, Monoclonal - immunology | Antirheumatic Agents - therapeutic use | Etanercept - therapeutic use | Immunoassay | Inflammatory bowel diseases | Systematic review | Arthritis | Inflammatory diseases | Proteins | Literature reviews | Infusion | Etanercept | Infliximab | Tumor necrosis factor-TNF | Ankylosing spondylitis | Immunoglobulins | Biological products | Psoriasis | Publications | Dermatology | Decision making | Rheumatology | Rheumatic diseases | Rituximab | Crohn's disease | Tumor necrosis factor-α | Patients | Diseases | Crohns disease | Inflammatory bowel disease | Studies | Spondylitis | Immunogenicity | Rheumatoid arthritis | Monoclonal antibodies | TNF inhibitors | Ulcerative colitis
Journal Article
Endocrine reviews, ISSN 0163-769X, 06/2012, Volume 33, Issue 3, pp. 456 - 492
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Fundamental and applied biological sciences. Psychology | Vertebrates: endocrinology | Biological and medical sciences | Obesity - drug therapy | Cardiovascular Diseases - drug therapy | Humans | Male | Obesity - blood | Neoplasms - blood | Accidental Falls - prevention & control | Musculoskeletal Diseases - blood | Cardiovascular Diseases - blood | Female | Musculoskeletal Diseases - drug therapy | Fetal Development - drug effects | Rats | Receptors, Calcitriol - metabolism | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Vitamin D - blood | Pregnancy | Diabetes Mellitus, Type 2 - blood | Animals | Quality of Life | Vitamin D - metabolism | Mice | Vitamin D - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Dietary Supplements | Skin - drug effects | Index Medicus | Reviews
Journal Article